Koren H Kwag
Overview
Explore the profile of Koren H Kwag including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
531
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tramacere I, Boncoraglio G, Banzi R, Del Giovane C, Kwag K, Squizzato A, et al.
BMC Med
. 2019 Mar;
17(1):67.
PMID: 30914063
Background: Statins may prevent recurrent ischemic events after ischemic stroke. Determining which statin to use remains controversial. We aimed to summarize the evidence for the use of statins in secondary...
2.
Vaona A, Banzi R, Kwag K, Rigon G, Cereda D, Pecoraro V, et al.
Cochrane Database Syst Rev
. 2018 Jan;
1:CD011736.
PMID: 29355907
Background: The use of e-learning, defined as any educational intervention mediated electronically via the Internet, has steadily increased among health professionals worldwide. Several studies have attempted to measure the effects...
3.
Liberati E, Ruggiero F, Galuppo L, Gorli M, Gonzalez-Lorenzo M, Maraldi M, et al.
Implement Sci
. 2017 Sep;
12(1):113.
PMID: 28915822
Background: Advanced Computerized Decision Support Systems (CDSSs) assist clinicians in their decision-making process, generating recommendations based on up-to-date scientific evidence. Although this technology has the potential to improve the quality...
4.
Moja L, Kwag K, Lytras T, Bertizzolo L, Brandt L, Pecoraro V, et al.
Am J Public Health
. 2014 Oct;
104(12):e12-22.
PMID: 25322302
We systematically reviewed randomized controlled trials (RCTs) assessing the effectiveness of computerized decision support systems (CDSSs) featuring rule- or algorithm-based software integrated with electronic health records (EHRs) and evidence-based knowledge....
5.
Moja L, Lucenteforte E, Kwag K, Bertele V, Campomori A, Chakravarthy U, et al.
Cochrane Database Syst Rev
. 2014 Sep;
(9):CD011230.
PMID: 25220133
Background: Neovascular age-related macular degeneration (AMD) is the leading cause of legal blindness in elderly populations of industrialised countries. Bevacizumab (Avastin®) and ranibizumab (Lucentis®) are targeted biological drugs (a monoclonal...